Multicenter clinical trials on a novel polyherbal formulation in allergic rhinitis

International Journal of Clinical Pharmacology Research

Volumn 24, Issue 2-3, 2004, Pages 79-94

  Saxena, V S ^a   Venkateshwarlu, K ^b   Nadig, P ^c   Barbhaiya, H C ^d   Bhatia, N ^e   Borkar, D M ^f   Gill, R S ^g   Jain, R K ^h   Katiyar, S K ⁱ   Nagendra Prasad, K V ^j   Nalinesha, K M ^k   Nasiruddin, K ^l   Rishi, J P ^m   Roy Chowdhury, J ⁿ   Saharia, P S ^o   Thomas, B ^p   Bagchi, D ^q  

^a Clinical Research Division   (India)

^b Anasuya Ayurveda Clinic   (India)

^c Vaidehi Inst of Medical Sciences   (India)

^d Jeevan Sandhya Center   (India)

^e KING GEORGE'S MEDICAL UNIVERSITY   (India)

^f KBHB Eye and ENT Hospital   (India)

^g ENT Clinic   (India)

^h BANARAS HINDU UNIVERSITY   (India)

ⁱ GSVM MEDICAL COLLEGE   (India)

^j Bangalore Allergy Centre   (India)

^k M S RAMAIAH MEDICAL COLLEGE   (India)

^l Karnataka Institute of Medical Sciences   (India)

^m SMS MEDICAL COLLEGE   (India)

ⁿ VIVEKANANDA INSTITUTE OF MEDICAL SCIENCES   (India)

^o Nasika   (India)

^p Asthma and Allergy Center   (India)

^q CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; IMMUNOGLOBULIN E; PLACEBO;

ABDOMINAL PAIN; ADULT; ALLERGIC RHINITIS; ANOREXIA; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; EOSINOPHIL; FATIGUE; FEMALE; GASTRITIS; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MUCOCILIARY CLEARANCE; MULTICENTER STUDY; MUSCLE WEAKNESS; NOSE CONGESTION; OPEN STUDY; PEAK EXPIRATORY FLOW; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RHINORRHEA; SNEEZING; THORAX DISEASE; TREATMENT OUTCOME; VOMITING; XEROSTOMIA;

ADULT; CHRONIC DISEASE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MEDICINE, HERBAL; MUCOCILIARY CLEARANCE; NASAL PROVOCATION TESTS; PATIENT DROPOUTS; PEAK EXPIRATORY FLOW RATE; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; RHINITIS, ALLERGIC, SEASONAL; SKIN TESTS; TREATMENT OUTCOME;

EID: 19944429100     PISSN: 02511649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Austen K.F. Disorders of immune mediated injury. "Harrison's Principles of Internal Medicine." Twelfth International Edition, McGraw-Hill, New York, 1991, pp. 1426.
2. Pawankar R. Allergic rhinitis: A disease of the modern society. Ind. J. Rhinology, 1, 8, 2001.
3. Oettgen H.C., Geha R.S. IgE in asthma and atopy: Cellular and molecular connections. J. Clin. Invest., 104, 829, 1999.
4. Fahy J.V., Fleming H.E., Wong H.H., Liu J.T., Su J.Q., Reimann J. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am. J. Respir. Crit. Care Med., 155, 1828, 1997.
5. Meltzer E.O., Jalowayski A.A., Orgel H.A., Harris A.G. Subjective and objective assessments in patients with seasonal allergic rhinitis: Effects of therapy with mometasone furoate nasal spray. J. Allergy Clin. Immunol., 102, 39, 1998.
6. "Management of Allergic Rhinitis and Its Impact on Asthma." In collaboration with the WHO, Geneva, Switzerland, 2001, pp. 1-23.
7. Hacki M.A., Hinz G.W., Medici T.C. Clinical experience over five years of daily therapy with formoterol in patients with bronchial asthma. Clin. Drug Invest., 14, 165, 1997.
8. "The Essential Guide to Prescription Drugs." Harper Collins, New York, 2001, pp. 689.
9. Agarwal R.K., Agarwal A. Assignee: Natural Remedies Pvt. Ltd., Bangalore, India. Herbal composition having antiallergic properties and a process for the preparation thereof. US Patent 6,730,332. May 4, 2004.
10. Amit A., Saxena V.S., Pratibha N., et al. Mast cell stabilization, lipoxygenase inhibition, hyaluronidase inhibition, antihistaminic and antispasmodic activities of Aller-7, a novel botanical formulation for allergic rhinitis. Drugs Exp. Clin. Res., 29, 107, 2003.
11. D'Souza R, Amit A., Saxena V.S., Bagchi M., Bagchi D. Antioxidant properties of Aller-7, a novel polyherbal formulation for allergic rhinitis. Drugs Exptl. Clin. Res., 30, 99, 2003.
12. Pratibha N., Saxena V.S., Amit A., D'Souza P., Bagchi M., Bagchi D. Anti-inflammatory activities of Aller-7, a novel polyherbal formulation for allergic rhinitis. Int. J. Tissue React., 26, 43, 2004.
13. Amit A., Saxena V.S., Pratibha N., Bagchi M., Bagchi D., Stohs S.J. Safety of a novel botanical extract formula for ameliorating allergic rhinitis. Toxicol. Mech. Meth., 13, 253, 2003.
14. Vyjayanthi G., Subhashchandra S., Saxena V.S., et al. Randomized double blind, placebo controlled trial of Aller-7 in patients with allergic rhinitis. Res. Comm. Pharmacol. Toxicol., 8, IV-23, 2003.
15. World Medical Association Declaration of Helsinki: World Drug information, Geneva, World Health Organization, 6, 186, 1992.
16. Taylor M.A., Reilly D., Jones L.R.H., McSharry C., Aitchison T. Randomized controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series. Brit. Med. J., 26, 321, 2000.
17. Addison G.M., Beamish M.R., Hales C.N., Hodgkins M., Jacobs A., Llewellin P. An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency on iron overload. J. Clin. Pathol., 25, 326, 1972.
18. Wanner A. Clinical aspects of mucociliary transport. Am. Rev. Respir. Dis., 116, 73, 1977.
19. Prieto L., Gutierrez V., Berto J.M., Tornero C., Camps B., Perez M.J. Relationship between airway responsiveness and peak expiratory flow variability in subjects with allergic rhinitis. Ann. Allergy Asthma Immunol., 75, 273, 1995.
20. Hamilos D.L., Thawley S.E., Kramper M.A., Kamil A., Hamid Q.A. Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease. J. Allergy Clin. Immunol., 103, 79, 1999.
21. Codina R., Ardusso L., Lockey R.F., Crisci C., Bertoya N.J. Sensitization to soybean hull allergens in subjects exposed to different levels of soybean dust inhalation in Argentina. Allergy Clin. Immunol., 105, 570, 2000.
22. US Department of Health and Human Services, Food & Drug Administration Center for Drug Evaluation and Research (CDER), Allergic Rhinitis Clinical Development Program, April 2000.
23. Testa B., Mesollella C., Mosti M.R., Mesollela M., Testa D., Motta G. Changes in serum interferon-gamma, interleukin-4, and interleukin-12 cytokine levels in anti-histamine type 2-treated allergic rhinitis patients. Laryngoscope, 111, 236, 2001.
24. Daly L.E., Bourke G.J. "Interpretation and Uses of Medical Statistics." Blackwell Science, Oxford, 1995, pp. 296-313.
25. Barnes P.J., Chung K.F., Page C.P. Inflammatory mediators of asthma: An update. Pharmacol. Rev., 50, 515, 1998.
26. Personal communication to VSS, Report No. ES-06C: NR-A2.
27. Bateman J.R., Pavia D., Sheahan N.F., Agnew J.E., Clarke S.W. Impaired tracheobronchial clearance in patients with mild stable asthma. Thorax, 38, 463, 1983.
28. Agnew J.E., Little F., Pavia D., Clarke S.W. Mucus clearance from the airways in chronic bronchitis: Smokers and ex-smokers. Bull. Eur. Physiopathol. Respir., 18, 473, 1982.
29. Lourenco R.V., Loddenkemper R., Carton R.W. Patterns of distribution and clearance of aerosols in patients with bronchiectasis. Am. Rev. Respir. Dis., 106, 857, 1972.
30. Singh I., Yadav J., Singh R., Raj B. Nasal mucociliary clearance in diseases of lower respiratory tract. Lung India, 14, 159, 1998.
31. Campbell W.B., Halushka P.V. Lipid-derived antacoids. In: Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W. (Eds.). "Goodman & Gillman's The Pharmacological Basis of Therapeutics." Ninth Edition, McGraw-Hill, New York, 1996, pp. 601-614.
32. Rajaram S., Suthakaran C., Pradhan S.C., Majumder N.K., Bapna J.S. Double-blind randomized clinical trial of cetirizine in the treatment of perennial allergic rhinitis. Ind. J. Pharmacol., 26, 112, 1994.
33. Brune K., Bickel D., Peskar B.A. Gastroprotective effects by extracts of Petasites hybridus. The role of inhibition of peptidoleukotrone synthesis. Planta Med., 59, 494, 1993.
34. Schapowal A. Randomized controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis. Brit. Med. J., 324, 144, 2000.